Current and historical daily PE Ratio for IOVA (
Iovance Biotherapeutics Inc
) from 2010 to Apr 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Iovance Biotherapeutics stock (IOVA) PE ratio as of Apr 17 2024 is 0.
More Details
Iovance Biotherapeutics Inc (IOVA) PE Ratio (TTM) Chart
Iovance Biotherapeutics Inc (IOVA) PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Total 1209
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Iovance Biotherapeutics PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-04-17 | At Loss | 2024-02-12 | At Loss |
2024-04-16 | At Loss | 2024-02-09 | At Loss |
2024-04-15 | At Loss | 2024-02-08 | At Loss |
2024-04-12 | At Loss | 2024-02-07 | At Loss |
2024-04-11 | At Loss | 2024-02-06 | At Loss |
2024-04-10 | At Loss | 2024-02-05 | At Loss |
2024-04-09 | At Loss | 2024-02-02 | At Loss |
2024-04-08 | At Loss | 2024-02-01 | At Loss |
2024-04-05 | At Loss | 2024-01-31 | At Loss |
2024-04-04 | At Loss | 2024-01-30 | At Loss |
2024-04-03 | At Loss | 2024-01-29 | At Loss |
2024-04-02 | At Loss | 2024-01-26 | At Loss |
2024-04-01 | At Loss | 2024-01-25 | At Loss |
2024-03-28 | At Loss | 2024-01-24 | At Loss |
2024-03-27 | At Loss | 2024-01-23 | At Loss |
2024-03-26 | At Loss | 2024-01-22 | At Loss |
2024-03-25 | At Loss | 2024-01-19 | At Loss |
2024-03-22 | At Loss | 2024-01-18 | At Loss |
2024-03-21 | At Loss | 2024-01-17 | At Loss |
2024-03-20 | At Loss | 2024-01-16 | At Loss |
2024-03-19 | At Loss | 2024-01-12 | At Loss |
2024-03-18 | At Loss | 2024-01-11 | At Loss |
2024-03-15 | At Loss | 2024-01-10 | At Loss |
2024-03-14 | At Loss | 2024-01-09 | At Loss |
2024-03-13 | At Loss | 2024-01-08 | At Loss |
2024-03-12 | At Loss | 2024-01-05 | At Loss |
2024-03-11 | At Loss | 2024-01-04 | At Loss |
2024-03-08 | At Loss | 2024-01-03 | At Loss |
2024-03-07 | At Loss | 2024-01-02 | At Loss |
2024-03-06 | At Loss | 2023-12-29 | At Loss |
2024-03-05 | At Loss | 2023-12-28 | At Loss |
2024-03-04 | At Loss | 2023-12-27 | At Loss |
2024-03-01 | At Loss | 2023-12-26 | At Loss |
2024-02-29 | At Loss | 2023-12-22 | At Loss |
2024-02-28 | At Loss | 2023-12-21 | At Loss |
2024-02-27 | At Loss | 2023-12-20 | At Loss |
2024-02-26 | At Loss | 2023-12-19 | At Loss |
2024-02-23 | At Loss | 2023-12-18 | At Loss |
2024-02-22 | At Loss | 2023-12-15 | At Loss |
2024-02-21 | At Loss | 2023-12-14 | At Loss |
2024-02-20 | At Loss | 2023-12-13 | At Loss |
2024-02-16 | At Loss | 2023-12-12 | At Loss |
2024-02-15 | At Loss | 2023-12-11 | At Loss |
2024-02-14 | At Loss | 2023-12-08 | At Loss |
2024-02-13 | At Loss | 2023-12-07 | At Loss |
Iovance Biotherapeutics Inc (IOVA) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Iovance Biotherapeutics Inc
NAICS : 325411
SIC : 2834
ISIN : US4622601007
Description